职业吸入剂暴露和患类风湿性关节炎的风险:系统性审查和元分析
Qianwen Liu1, Xin Song2, Emily Mauro3
1Department of Clinical Neuroscience, Karolinska Institutet, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Arthritis & rheumatology (Hoboken, N.J.)
|November 28, 2025
概括
职业吸入剂暴露,包括二氧化和石棉,与患类风湿性关节炎 (RA) 的风险更高有关. 这凸显了需要采取工作场所安全措施,以防止RA.
科学领域:
- 类风湿病学 类风湿病学
- 职业健康 职业健康 职业健康
- 环境医学 环境医学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,具有吸烟等已知的危险因素.
- 职业吸入剂暴露对RA发展的影响不太清楚.
- 这项研究解决了有关工作场所吸入剂和RA风险的知识差距.
研究的目的:
- 系统地审查和综合有关职业吸入剂暴露与类风湿性关节炎 (RA) 风险之间的相关证据.
- 量化与各种职业吸入剂相关的RA风险.
- 为工作场所预防策略和未来研究提供信息.
主要方法:
- 一个系统的审查和元分析,遵循PRISMA指南.
- 在Medline,Embase和Web of Science数据库中进行了搜索.
- 包括基于人口的横截面,病例控制和队列研究,具有可靠的RA确定和暴露数据.
主要成果:
- 对25项涉及10种类型职业吸入剂的研究进行了元分析.
- 对于二氧化,石棉,溶剂,农药,肥料,动物灰尘和发动机废气,发现了显著的RA风险增加 (RR 1.25-1.49).
- 在七个元分析中发现了中等到高的异质性.
结论:
- 职业吸入剂暴露与风湿性关节炎的风险增加有关.
- 工作场所的预防策略对于减轻RA风险至关重要.
- 对将吸入物与RA联系起来的生物机制进行进一步的研究是有必要的.
相关概念视频
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K


